<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="teaser">
 <p>In this paper, we make the scientific argument for an increase in clinical trials treating SARS Co-V-2 early during infection. Early treatment of SARS-CoV-2 could disproportionately lower the mortality rate, but also lower hospitalization and decrease ongoing transmission of virus.</p>
</abstract>
